Company Name: |
Shanghai jing Hao pharmaceutical technology co., LTD Gold
|
Tel: |
021-68900963 15618693615 |
Email: |
sales@jinghaopharma.com |
Products Intro: |
Product Name:Cis cyclohexane carboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]- CAS:2778223-52-0
|
Company Name: |
Shanghai Boc Chemical Co.,Ltd
|
Tel: |
021-34975603-808 18721111801 |
Email: |
sales@bocpharma.com |
Products Intro: |
Product Name:Cis cyclohexane carboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]- CAS:2778223-52-0 Purity:98% HPLC Package:5KG;1KG
|
Company Name: |
SHANGHAI FDC-CHEMICAL CO.,LTD
|
Tel: |
021-61469567 18521078705 |
Email: |
sales@fdc-chemical.com |
Products Intro: |
Product Name:Cis cyclohexane carboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]- CAS:2778223-52-0 Purity:95% Package:1g
|
Company Name: |
Henan Alfachem Co.,Ltd.
|
Tel: |
0371-0371-55051623 18137891487 |
Email: |
2853979817@qq.com |
Products Intro: |
CAS:2778223-52-0 Purity:98% Package:100mg;250mg;500mg;1g;5g;10g;25g;50g;100g;250g;500g;1kg;5kg;10kg;25kg Remarks:Sealed in dry,Room Temperature
|
|
| Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Basic information |
| Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Chemical Properties |
Boiling point | 597.6±50.0 °C(Predicted) | density | 1.32±0.1 g/cm3(Predicted) | pka | 4.23±0.44(Predicted) | InChI | InChI=1S/C17H23N5O3/c1-10-8-13(19-14-9-11(2)21-22-14)20-15(18-10)12-4-6-17(25-3,7-5-12)16(23)24/h8-9,12H,4-7H2,1-3H3,(H,23,24)(H2,18,19,20,21,22)/t12-,17- | InChIKey | QKVACMCXFIAPPC-QASKLWRZSA-N | SMILES | [C@]1(OC)(C(O)=O)CC[C@H](C2=NC(NC3C=C(C)NN=3)=CC(C)=N2)CC1 |
| Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Usage And Synthesis |
Uses |
Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- could be used to synthesise Pralsetinib which is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer.
|
| Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Preparation Products And Raw materials |
|